Product/Composition:- | Metformin Extended-Release (ER/XR) Tablets |
---|---|
Strength:- | 500 mg, 750 mg, 1000 mg |
Form:- | Extended-Release (ER/XR) Tablets |
Reference Brands:- | Glucophage XR®, Fortamet®, Glumetza® |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Metformin ER/XR reduces hepatic glucose production, enhances insulin sensitivity, and improves peripheral glucose uptake. Its extended-release formulation ensures gradual drug release, minimizing gastrointestinal side effects. Benefits include effective blood sugar control, improved adherence with once-daily dosing, and weight neutrality, making it a first-line therapy for type 2 diabetes management.
Metformin Extended-Release (ER/XR) tablets are approved in both the USA and EU for the treatment of type 2 diabetes mellitus. In the USA, they are regulated under the FDA’s NDA and ANDA pathways, with several generic approvals available. Common brands include Glucophage XR and Fortamet. In the EU, Metformin ER is authorized via national procedures and is included in multiple Member States' formularies. ER formulations improve gastrointestinal tolerability and enhance patient adherence by allowing once-daily dosing. Pharmatradz.com supports global buyers in sourcing Metformin ER tablets from GMP-certified manufacturers compliant with FDA and EMA quality standards.